BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19564968)

  • 1. Advise against metamizole.
    Neumann J
    Dtsch Arztebl Int; 2009 Jan; 106(4):55-6; author reply 56. PubMed ID: 19564968
    [No Abstract]   [Full Text] [Related]  

  • 2. The incidence of metamizole sodium-induced agranulocytosis in Poland.
    Maj S; Lis Y
    J Int Med Res; 2002; 30(5):488-95. PubMed ID: 12449518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
    Lampl C; Likar R
    Schmerz; 2014 Dec; 28(6):584-90. PubMed ID: 25199942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic use of metamizole: not so safe after all?
    Vuik FE; Koehestanie P; Herbers AH; Terhaar Sive Droste JS
    Neth J Med; 2017 Mar; 75(2):81-83. PubMed ID: 28276328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe thrombocytopenia and agranulocytosis associated with metamizole].
    Fernández García PL; Ibáñez Camacho MF; López Pérez E
    Med Clin (Barc); 2016 Oct; 147(8):e43-e44. PubMed ID: 27450174
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dual agranulocytosis episode likely resulting from metamizole use].
    Hemmersbach-Miller M; Conde Martel A; Acosta Artiles M; Suárez Ortega S
    Farm Hosp; 2005 Mar; 29(2):148-50. PubMed ID: 16045431
    [No Abstract]   [Full Text] [Related]  

  • 7. Dipyrone (metamizole) use in the United States: a lethal tango?
    Moorman J
    South Med J; 2006 Sep; 99(9):916. PubMed ID: 17004522
    [No Abstract]   [Full Text] [Related]  

  • 8. [Case Report - Metamizole-Induced Agranulocytosis].
    Gonnert FA; Meißner W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 May; 53(5):388-394. PubMed ID: 29772595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fatal agranulocytosis after metamizole reexposure].
    Zeiner E; Blaser LS; Tisljar K; Heim D; Taegtmeyer A
    Praxis (Bern 1994); 2015 Jan; 104(3):151-4. PubMed ID: 25626384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyrone and agranulocytosis: what is the risk?
    Edwards JE; McQuay HJ
    Lancet; 2002 Nov; 360(9344):1438. PubMed ID: 12433507
    [No Abstract]   [Full Text] [Related]  

  • 11. [Agranulocytosis from metamizole: a potential problem for the British population].
    Mérida Rodrigo L; Faus Felipe V; Poveda Gómez F; García Alegría J
    Rev Clin Esp; 2009 Apr; 209(4):176-9. PubMed ID: 19457324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipyrone and agranulocytosis: what is the risk?
    Schönhöfer P; Offerhaus L; Herxheimer A
    Lancet; 2003 Mar; 361(9361):968-9. PubMed ID: 12648993
    [No Abstract]   [Full Text] [Related]  

  • 13. Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child.
    Işık M; Kaya Z; Belen FB; Aktaş AT; Tezer H; Gürsel T
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):e46-8. PubMed ID: 23007418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metamizole (dipyrone)-induced agranulocytosis: Does the risk vary according to ethnicity?
    Shah RR
    J Clin Pharm Ther; 2019 Feb; 44(1):129-133. PubMed ID: 30311250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017.
    Hoffmann F; Bantel C; Jobski K
    Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):116-125. PubMed ID: 31449718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dipyrone (metamizole) : Considerations on monitoring for early detection of agranulocytosis].
    Stamer UM; Gundert-Remy U; Biermann E; Erlenwein J; Meiβner W; Wirz S; Stammschulte T
    Schmerz; 2017 Feb; 31(1):5-13. PubMed ID: 27766404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.
    Bäckström M; Hägg S; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002; 11(3):239-45. PubMed ID: 12051124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs.
    Konijnenbelt-Peters J; van der Heijden C; Ekhart C; Bos J; Bruhn J; Kramers C
    Pain Pract; 2017 Mar; 17(3):402-408. PubMed ID: 27346584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated-type Reactions to High Parenteral Doses of Metamizole in Patients Who Tolerated Therapeutic Doses of Oral Metamizole and Other NSAIDs.
    Prados M; Labella M; Baynova K
    J Investig Allergol Clin Immunol; 2016; 26(6):378-379. PubMed ID: 27996946
    [No Abstract]   [Full Text] [Related]  

  • 20. [Surgery, dipyrone, and agranulocytosis in Latin America].
    Sánchez Medal L
    Sangre (Barc); 1997 Oct; 42(5):343-4. PubMed ID: 9424731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.